Literature DB >> 32105626

Dolutegravir-associated hyperglycaemia in patients with HIV.

Mohammed Lamorde1, Martha Atwiine2, Noela C Owarwo2, Ahmed Ddungu2, Eva O Laker2, Frank Mubiru2, Agnes Kiragga2, Isaac B Lwanga2, Barbara Castelnuovo2.   

Abstract

Entities:  

Year:  2020        PMID： 32105626     DOI： 10.1016/S2352-3018(20)30042-4

Source DB:  PubMed          Journal:  Lancet HIV        ISSN： 2352-3018            Impact factor:   12.767


× No keyword cloud information.
  20 in total

Review 1.  Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps.

Authors:  Anushka Naidoo; Kogieleum Naidoo; Nesri Padayatchi; Kelly E Dooley
Journal:  Lancet HIV       Date:  2022-02       Impact factor: 12.767

Review 2.  Metabolic Consequences of Antiretroviral Therapy.

Authors:  Caroline E Diggins; Samuel C Russo; Janet Lo
Journal:  Curr HIV/AIDS Rep       Date:  2022-03-17       Impact factor: 5.071

3.  "It's only fatness, it doesn't kill": a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda.

Authors:  Yussif Alhassan; Adelline Twimukye; Thokozile Malaba; Landon Myer; Catriona Waitt; Mohammed Lamorde; Angela Colbers; Helen Reynolds; Saye Khoo; Miriam Taegtmeyer
Journal:  BMC Womens Health       Date:  2022-06-21       Impact factor: 2.742

4.  Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial.

Authors:  Ronald Kiguba; Norah Mwebaza; Ronald Ssenyonga; Helen Byomire Ndagije; Victoria Nambasa; Cordelia Katureebe; Kenneth Katumba; Phil Tregunno; Kendal Harrison; Charles Karamagi; Kathryn A Scott; Munir Pirmohamed
Journal:  BMJ Open       Date:  2022-07-01       Impact factor: 3.006

5.  Weight gain stopping/switch rules for antiretroviral clinical trials.

Authors:  W D Francois Venter; Simiso Sokhela; Alexandra Calmy; Luckyboy Mkhondwane; Bronwyn Bosch; Nomathemba Chandiwana; Andrew Hill; Kenly Sekwese; Nkuli Mashabane; Anton Pozniak; Saye Khoo; Mohammed Ali; Eric Delaporte; Samanta Lalla-Edwards; Polly Clayden; Vincent C Marconi; Mark J Siedner; Marta Boffito; Celicia Serenata; Mary Carman; Simon Collins
Journal:  AIDS       Date:  2021-12-15       Impact factor: 4.632

Review 6.  Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy.

Authors:  Sahera Dirajlal-Fargo; Grace A McComsey
Journal:  Curr HIV/AIDS Rep       Date:  2021-10-15       Impact factor: 5.495

7.  Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy.

Authors:  K N Mmasa; K Powis; S Sun; J Makhema; M Mmalane; S Kgole; G Masasa; S Moyo; M Gerschenson; T Mohammed; J Legbedze; E J Abrams; I J Kurland; M E Geffner; J Jao
Journal:  HIV Med       Date:  2021-05-18       Impact factor: 3.094

8.  Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.

Authors:  Peter F Rebeiro; Cathy A Jenkins; Aihua Bian; Jordan E Lake; Kassem Bourgi; Richard D Moore; Michael A Horberg; W Christopher Matthews; Michael J Silverberg; Jennifer Thorne; Angel M Mayor; Viviane D Lima; Frank J Palella; Michael S Saag; Keri N Althoff; M John Gill; Cherise Wong; Marina B Klein; Heidi M Crane; Vincent C Marconi; Bryan E Shepherd; Timothy R Sterling; John R Koethe
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 20.999

9.  Efficacy and safety of a single-tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV-1-infected subjects on nonnucleoside reverse transcriptase inhibitor-containing first-line antiretroviral therapy in Pune, India.

Authors:  A Dravid; T P Betha; A K Sharma; R Gawali; U Mahajan; M Kulkarni; C Saraf; S Kore; M Dravid; N Rathod
Journal:  HIV Med       Date:  2020-07-20       Impact factor: 3.180

10.  Integrase Strand Transfer Inhibitors and Weight Gain in Children and Youth With Perinatal Human Immunodeficiency Virus in the DC Cohort.

Authors:  Wei Li A Koay; Sahera Dirajlal-Fargo; Matthew E Levy; Paige Kulie; Anne Monroe; Amanda D Castel; Natella Y Rakhmanina
Journal:  Open Forum Infect Dis       Date:  2021-07-01       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.